Michelle Rozo is vice chair of the National Security Commission on Emerging Biotechnology, a US legislative branch advisory entity charged with conducting a thorough review of how advancements in emerging biotechnology and related technologies shape the Department of Defense’s current and future activities. She is also vice president of technical capabilities at In-Q-Tel, a nonprofit strategic investor that accelerates the development and delivery of cutting-edge technologies to enhance US national security.
Rozo was previously director of technology and national security on the US National Security Council, where she advised the president and national security adviser on biotechnology and national security policy. She was also the principal director for biotechnology within the Office of the Under Secretary of Defense for Research and Engineering.
Rozo is a molecular biologist by training and studied severe infectious diseases as a staff scientist with the Naval Medical Research Center in Fort Detrick, Maryland. She holds a PhD in biology from the Cell, Molecular, Developmental Biology and Biophysics Program at Johns Hopkins University, and a bachelor’s degree in biology from Northwestern University.